BILLERICA, Mass.--(BUSINESS WIRE)--
Bruker Corporation (NASDAQ:BRKR) today announced that it has appointed
Dr. Robert Rosenthal to its Board of Directors, effective immediately.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20151116005463/en/
Dr. Robert Rosenthal Joins Bruker's Board of Directors (Photo: Business Wire)
Dr. Rosenthal currently serves as Chief Executive Officer and as a
director for Taconic Biosciences, Inc., a privately-held provider of
research models for the pharmaceutical and biotech industry, a position
he has held since joining Taconic Biosciences in June 2014.
Prior to joining Taconic Biosciences, Dr. Rosenthal held a variety of
senior management positions with companies involved in the development
of diagnostics, therapeutics, medical devices, and life sciences tools,
most recently as Chairman and Chief Executive Officer of Intelligent
Medical Implants, AG, a medical technology company.
He has also served as President and Chief Executive Officer of Magellan
Biosciences, Inc., a provider of clinical diagnostics and life sciences
research tools. Dr. Rosenthal also serves as a director of Safeguard
Scientifics, Inc., a publicly-traded provider of capital for early- and
growth-stage companies, and for Galvanic Applied Sciences, Inc., a
privately held Canadian company. Earlier in his career, Dr. Rosenthal
held senior management positions at PerkinElmer Inc. and Thermo Fisher
Scientific, Inc. He holds a Ph.D. from Emory University and a Master of
Science degree from the State University of New York.
Frank Laukien, the President and CEO of Bruker, stated: “Dr. Rosenthal’s
success as an entrepreneur, and his extensive understanding of the
diagnostics and life science tools industries, will make him a valuable
addition to our Board. Bob will help to guide our efforts to create
innovative new products and expand into defensible markets with high
margin potential.”
Dr. Rosenthal commented: “Bruker has a long history of innovation,
leadership and success in analytical instrumentation. I believe there
are many opportunities to apply Bruker’s analytical technologies to new
applications and diagnostic areas. I look forward to assisting Bruker in
identifying such new opportunities for profitable growth, and it is an
honor to join the Bruker board.”
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve the
quality of human life. Bruker’s high-performance scientific research
instruments and high-value analytical solutions enable scientists to
explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation,
productivity and customer success in life science molecular research, in
applied and pharma applications, and in microscopy, nano-analysis and
industrial applications, as well as in cell biology, preclinical
imaging, clinical research, microbiology and molecular diagnostics. For
more information, please visit: http://www.bruker.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151116005463/en/
Source: Bruker Corporation